Work

The Receptor for Hyaluronic Acid Mediated Motility (RHAMM/CD168) Is a Potential Target for Immunotherapy of Patients with B-Cell Chronic Lymphocytic Leukemia.

Year: 2005

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v106.11.53.53

Authors: Krzysztof Giannopoulos, Iwona Hus, Li Li, Agnieszka Bojarska-Junak, Jochen Greiner, Jacek Rolinski, Anna Dmoszynska, Hartmut Doehner, Michael Schmitt

Institutions: Medical University of Lublin, Universität Ulm

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2516315956

FWCI: 0.296

Cites:

Cited by: 4

Related to: 10